Alpine Peaks Capital, LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Alpine Peaks Capital, LP reported 20 stock positions worth $98.9 million. Its top holding was Bright Horizons Family Solut (BFAM) at 7.7% of the portfolio, followed by West Pharmaceutical Services (WST, 7.6%) and U.S. Physical Therapy (USPH, 7.2%). Compared with Q4 2025, it added to 11 and reduced 8. The biggest buy was Bio-Techne (TECH, shares +44%) and the biggest sale Trimble (TRMB, shares −6%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001906602
- Portfolio Value
- $98.9M (Q1 2026)
- SEC Filing
- 0001906602-26-000002 ↗ filed May 15, 2026
Holdings Value
Holdings 20 stocks · $98.9M
| BFAM Bright Horizons Family Solut | 7.71% | 92,851 | $7.6M | Add +3.6% |
| WST West Pharmaceutical Services | 7.57% | 29,883 | $7.5M | Add +12.8% |
| USPH U.S. Physical Therapy Inc. | 7.20% | 95,024 | $7.1M | Add +4.2% |
| HEI.A Heico Corp. Class A | 7.19% | 33,669 | $7.1M | Add +7.0% |
| CGNX Cognex Corp. | 6.04% | 121,919 | $6.0M | Reduce -11.7% |
| LFUS Littelfuse Inc. | 5.87% | 17,100 | $5.8M | Reduce -16.2% |
| MEDP Medpace Holdings Inc. | 5.51% | 11,356 | $5.5M | Add +19.5% |
| EVTC Evertec Inc. | 5.37% | 188,204 | $5.3M | Add +4.7% |
| JKHY Jack Henry & Associates Inc. filed as HENRY JACK & ASSOC INC | 5.15% | 32,247 | $5.1M | Add +7.3% |
| TRMB Trimble Inc. | 5.01% | 75,983 | $5.0M | Reduce -6.3% |
| ROL Rollins Inc. | 4.86% | 89,968 | $4.8M | Reduce -12.6% |
| DSGX The Descartes Systems Grp | 4.62% | 63,900 | $4.6M | Add +25.3% |
| TREX Trex Company Inc. filed as TREX INC | 4.51% | 122,339 | $4.5M | Reduce -0.4% |
| WAB Wabtec Corp. | 4.42% | 17,480 | $4.4M | Reduce -14.7% |
| WMS Advanced Drainage Systems Inc. | 4.25% | 30,670 | $4.2M | Reduce -0.8% |
| TECH Bio-Techne Corp. | 3.91% | 74,000 | $3.9M | Add +43.7% |
| IPAR Interparfums Inc. | 3.42% | 37,202 | $3.4M | Reduce -21.0% |
| QLYS Qualys Inc. | 3.10% | 34,905 | $3.1M | Add +6.1% |
| BBSI Barrett Business SVCS Inc. | 2.61% | 88,352 | $2.6M | No change |
| TNET Trinet Group Inc. | 1.68% | 45,650 | $1.7M | Add +15.1% |
Options reported separately and not counted above: MRVI calls ($283K).
Portfolio Sells Q4 2025 → Q1 2026
| TRMB Trimble Inc. | Reduce -6.3% | 5.01% | −1.05 |
| ROL Rollins Inc. | Reduce -12.6% | 4.86% | −1.04 |
| IPAR Interparfums Inc. | Reduce -21.0% | 3.42% | −0.40 |
| WMS Advanced Drainage Systems Inc. | Reduce -0.8% | 4.25% | −0.02 |
| WAB Wabtec Corp. | Reduce -14.7% | 4.42% | +0.24 |
| TREX Trex Company Inc. | Reduce -0.4% | 4.51% | +0.39 |
| LFUS Littelfuse Inc. | Reduce -16.2% | 5.87% | +0.94 |
| CGNX Cognex Corp. | Reduce -11.7% | 6.04% | +1.30 |
Portfolio Buys Q4 2025 → Q1 2026
| TECH Bio-Techne Corp. | Add +43.7% | 3.91% | +1.02 |
| WST West Pharmaceutical Services | Add +12.8% | 7.57% | +0.62 |
| MEDP Medpace Holdings Inc. | Add +19.5% | 5.51% | +0.42 |
| USPH U.S. Physical Therapy Inc. | Add +4.2% | 7.20% | +0.40 |
| EVTC Evertec Inc. | Add +4.7% | 5.37% | +0.38 |
| DSGX The Descartes Systems Grp | Add +25.3% | 4.62% | +0.35 |
| JKHY Jack Henry & Associates Inc. | Add +7.3% | 5.15% | −0.08 |
| HEI.A Heico Corp. Class A | Add +7.0% | 7.19% | −0.40 |
| TNET Trinet Group Inc. | Add +15.1% | 1.68% | −0.56 |
| BFAM Bright Horizons Family Solut | Add +3.6% | 7.71% | −0.97 |
| QLYS Qualys Inc. | Add +6.1% | 3.10% | −1.08 |
Options Activity Q4 2025 → Q1 2026
| MRVI Maravai Lifesciences Hldgs-A | call | Add +3.2% | 100,000 | $283K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 20 | $85.4M | HEI.A, WST, CGNX, BFAM, USPH |
| Q1 2026 | 20 | $98.9M | BFAM, WST, USPH, HEI.A, CGNX |
| Q4 2025 | 20 | $104.7M | BFAM, HEI.A, WST, USPH, TRMB |
| Q3 2025 | 23 | $114.7M | HEI.A, BFAM, USPH, WST, CGNX |
| Q2 2025 | 23 | $113.3M | HEI.A, BFAM, CGNX, USPH, TRMB |
| Q1 2025 | 25 | $110.9M | BFAM, HEI.A, ROL, MEDP, CGNX |
| Q4 2024 | 23 | $121.8M | BFAM, ROL, HEI.A, TRMB, CGNX |
| Q3 2024 | 23 | $167.5M | ROL, IPAR, CGNX, TRMB, MEDP |
| Q2 2024 | 25 | $162.9M | ROL, IPAR, CGNX, MEDP, WAB |
| Q1 2024 | 23 | $173.6M | IPAR, ROL, MEDP, CGNX, WAB |